Allergen Epitope Research and Validation Cnters (U19)

The summary for the Allergen Epitope Research and Validation Cnters (U19) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Allergen Epitope Research and Validation Cnters (U19)
	CFDA Number:	93.855
	CFDA Description:	Allergy, Immunology and Transplantation Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-11-013
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Apr 07, 2011
	Creation Date:	Apr 07, 2011
	Original Closing Date for Applications:	Jul 22, 2011
	Current Closing Date for Applications:	Jul 22, 2011
	Archive Date:	Aug 22, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	2,800,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Description: The purpose of this FOA is to capitalize on the availability of well characterized T cell allergen epitopes to study allergen-specific immune responses.. As part of the characterization and validation of these allergen T cell epitopes, there is a need to conduct mechanistic studies that focus on the progression and/or changes in the severity of seasonal or perennial allergic diseases (e.g. seasonal allergic rhinitis, asthma exacerbations triggered by pet dander), as well as the changes resulting from therapeutic intervention in allergic disease, such as immunotherapy for seasonal, perennial, or food allergies. Programs should focus on mechanistic assessment of T cell allergen epitopes to illuminate the T cell phenotypes, their function and contribution to allergen-specific T-cell memory. Limited novel T cell allergen epitope identification will also be supported under this FOA, but only as a companion to, and extension of, mechanistic studies of T cell responses to existing allergen epitopes.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-ai-11-013.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Innovation for HIV Vaccine Discovery (R01); • NIAID Clinical Trial Implementation Cooperative Agreement (U01); • Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33); • Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01); • Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Inj...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers; • Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01); • Asthma and Allergic Diseases Cooperative Research Centers (U19)